Intervention Protocol

Vascular closure devices for femoral arterial puncture site haemostasis

  1. Charlie C-T Hsu1,*,
  2. Gigi NC Kwan2,
  3. John A Rophael3,
  4. Chris Anthony1,
  5. Mieke L van Driel4,5,6

Editorial Group: Cochrane Peripheral Vascular Diseases Group

Published Online: 18 JAN 2012

DOI: 10.1002/14651858.CD009541

How to Cite

Hsu CCT, Kwan GNC, Rophael JA, Anthony C, van Driel ML. Vascular closure devices for femoral arterial puncture site haemostasis (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 1. Art. No.: CD009541. DOI: 10.1002/14651858.CD009541.

Author Information

  1. 1

    The Alfred Hospital, Prahran, Victoria, Australia

  2. 2

    Box Hill Hospital, Box Hill, Victoria, Australia

  3. 3

    University of Melbourne, Department of Surgery - St Vincent's Hospital, Fitzroy, Victoria, Australia

  4. 4

    Bond University, Faculty of Health Sciences and Medicine, Gold Coast, QLD, Australia

  5. 5

    Ghent University, Department of General Practice and Primary Health Care, Ghent, Belgium

  6. 6

    University of Queensland, Discipline of General Practice, School of Medicine, Brisbane, Queensland, Australia

*Charlie C-T Hsu, The Alfred Hospital, Commercial Road, Prahran, Victoria, 3181, Australia.

Publication History

  1. Publication Status: New
  2. Published Online: 18 JAN 2012




  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The aim of this review is to determine the efficacy and safety of VCD versus the traditional methods of MC or MCD, or both, to achieve haemostasis after both retrograde and antegrade percutaneous arterial puncture of the CFA. In addition, the utility of VCDs in the setting of percutaneous EVAR will also be evaluated. This review will provide an overview of existing evidence on the full utility of VCDs and other methods to achieve haemostasis in every aspect of diagnostic and interventional procedures.